Prevalence and Prognostic Significance of Dysglicemia in Patients With Type 2 Diabetes Mellitus at the Stage of Decompensation of Chronic Cardiac Failure
Bibliographic Data
| ID | 5968433 |
|---|---|
| Authors | M Yu Ishekova (Northern State Medical University), I V Dvoryashina (Northern State Medical University), K K Kholmatova, Kamila Kholmatova (0000-0002-5240-6470, Centre for Arctic Gas Hydrate, Environment and Climate), A M Grjibovski, Andrej М Grjibovski (0000-0002-5464-0498, North-Eastern Federal University) |
| Year | 2019 |
| Volume | 26 |
| Issue | 11 |
| Pages | 48-54 |
| Publication date | 2019-11-15 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Ekologiya Cheloveka (Human Ecology (JOURNAL) |
| Journal identifiers | ISSN: 1728-0869 • E-ISSN: 2949-1444 |
| Publisher | ECO-Vector LLC (PUBLISHER • RU) |
| DOI | 10.33396/1728-0869-2019-11-48-54 |
| OpenAlex | W2988033460 |
| Language | EN |
| References cited | 14 |
The aim was to study the prevalence of dysglycemia and glycemic variability (GV) during hospitalization for chronic heart failure (CHF) decompensation and their effect on four-years survival. Methods: A retrospective analysis of the hospital records of 279 patients with type 2 diabetes mellitus (DM), hospitalized with CHF decompensation to the First City Clinical Hospital in Arkhangelsk was performed. Mann - Whitney tests were used for numeric variables. Simple and multiple logistic regression analyses were used to determine the effect of glycemia at admission, GV indicators on the early and long-term prognosis. Results: Median blood glucose at hospitalization was 8.80 (6.74; 11.04) mmol/l. Off-target glycemia was observed in 245 (87.8 %) patients. More than half of the measured tests during hospitalization had glycemic values beyond the recommended levels for the hospitalization period (82.6 %). In patients who died in the long-term period (n = 64, 28.1 %), hyperglycemia of more than 10.0 mmol/l was observed in 43.8 % of the measured tests during hospitalization, in 18.3 % - hyperglycemia from 7.8 to 10.0 mmol/l. Patients who died in the long-term period had higher indices of GV in comparison with the survivors (p = 0.004 for glycemic level variation, p = 0.008 for standard deviation and p = 0.001 for variation coefficient). High GV was associated (OR: 1.943; CI 1.013-3.725, p = 0.046) with the outcome, regardless of gender, manifestations of heart failure and renal function. Conclusions. Altogether, 87.8 % of patients had dysglycemia during the period of hospitalization. High GV during hospitalization was observed in 50.2 % of patients. High GV during hospitalization is an independent risk factor for for-years mortality
Cardiac decompensation · Cardiology · Decompensation · Diabetes mellitus · Glycemic · Heart failure · Insulin · Logistic regression · Cardiovascular Function and Risk Factors · Diabetes Treatment and Management · Hyperglycemia and glycemic control in critically ill and hospitalized patients · Medicine · Endocrinology · Internal Medicine
| Highly cited | No |
|---|